RO5095932

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Diabetes Mellitus Type 2

Phase 1

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

CompletedNCT00961909

Hoffmann-La RocheDiabetes Mellitus Type 2

Start: 2009-06-30End: 2010-10-31Updated: 2016-11-02

A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.

CompletedNCT01017302

Hoffmann-La RocheDiabetes Mellitus Type 2

Start: 2009-12-31End: 2011-08-31Updated: 2016-11-02